Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kyle Rove to Antineoplastic Agents

This is a "connection" page, showing publications Kyle Rove has written about Antineoplastic Agents.

 
Connection Strength
 
 
 
0.251
 
  1. Rove KO, Flaig TW. A renaissance in the medical treatment of advanced prostate cancer. Oncology (Williston Park). 2010 Dec; 24(14):1308-13, 1318.
    View in: PubMed
    Score: 0.161
  2. Crawford ED, Rove KO. Advanced prostate cancer: therapeutic sequencing, outcomes, and cost implications. Am J Manag Care. 2012 12; 18(5 Spec No.):SP250-3.
    View in: PubMed
    Score: 0.046
  3. Rove KO, Crawford ED. Evolution of treatment options for patients with CRPC and bone metastases: bone-targeted agents that go beyond palliation of symptoms to improve overall survival. Oncology (Williston Park). 2011 Dec; 25(14):1362-70, 1375-81, 1387.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)